Market cap
₹70 Cr
Revenue (TTM)
₹59 Cr
P/E Ratio
13.8
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
7.8 %
-
ROCE
10.1 %
-
Industry P/E
36.92
-
EV/EBITDA
6.8
-
Debt to Equity
0
-
Book Value
₹46.3
-
EPS
₹3.6
-
Face value
10
-
Shares outstanding
14,650,854
10 Years Aggregate
CFO
₹-8.03 Cr
EBITDA
₹2.64 Cr
Net Profit
₹1.20 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Eiko Lifesciences
| -12.8 | -2.6 | -10.0 | -8.6 | -7.2 | -11.2 | -- |
|
BSE Commodities
| 9.7 | 2.7 | -1.2 | 13.5 | 16.4 | 9.7 | 14.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Eiko Lifesciences
| -10.5 | 0.8 | 51.5 | -33.1 | 111.9 | 124.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Eiko Lifesciences
|
48.0 | 70.3 | 58.8 | 5.6 | 11.7 | 8 | 13.8 | 1.0 |
| 540.4 | 19,601.8 | 9,013.0 | 531.0 | 9.4 | 9 | 36.9 | 3.2 | |
| 1,696.8 | 22,521.3 | 1,223.9 | 235.2 | 25.4 | 10 | 95.8 | 9.0 | |
| 1,260.4 | 14,311.5 | 2,534.6 | 225.0 | 15.7 | 5.4 | 81.9 | 4.3 | |
| 1,762.9 | 24,046.8 | 8,574.8 | 783.4 | 12.8 | 14 | 30.7 | 3.9 | |
| 5,282.5 | 16,175.3 | 2,471.6 | 442.5 | 19.3 | 17 | 36.9 | 5.8 | |
| 7,224.5 | 16,798.7 | 2,258.2 | 387.9 | 19.9 | 15 | 43.3 | 6.0 | |
| 683.5 | 10,919.5 | 4,650.6 | 308.8 | 9.4 | 10.3 | 35.4 | 3.4 | |
| 3,458.0 | 13,515.1 | 2,671.1 | 342.0 | 19.5 | 26.4 | 38.6 | 9.0 | |
| 1,325.2 | 13,730.0 | 2,380.8 | 448.4 | 23.0 | 14.7 | 30.6 | 4.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Eiko Lifesciences
Trusts, funds and other financial vehicles
-
Incorporated
1977
-
Chairman
Laxmikant Ramprasad Kabra
-
Managing Director
--
-
Headquarters
Thane, Maharashtra
-
Website
Looking for more details about Eiko Lifesciences Ltd.’s IPO? Explore our IPO Details page.
FAQs for Eiko Lifesciences
What is the current share price of Eiko Lifesciences Ltd Today?
The share price of Eiko Lifesciences Ltd is ₹47.99 (BSE) as of 28-Aug-2026 IST. Eiko Lifesciences Ltd has given a return of -7.24% in the last 3 years.
What is the current PB & PE ratio of Eiko Lifesciences Ltd?
The P/E ratio of Eiko Lifesciences Ltd is 13.81 times as on 28-Aug-2026, a 63 discount to its peers’ median range of 36.92 times.
The P/B ratio of Eiko Lifesciences Ltd is 1.04 times as on 28-Aug-2026, a 63 discount to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
34.20 |
1.27 |
2024 |
88.56 |
1.31 |
2023 |
71.65 |
2.16 |
2022 |
49.53 |
1.41 |
2021 |
49.25 |
4.89 |
What is the 52 Week High and Low of Eiko Lifesciences Ltd?
The 52-week high and low of Eiko Lifesciences Ltd are Rs 64.44 and Rs 44.75 as of 29-Aug-2026.
What is the market cap of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has a market capitalisation of ₹ 70 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Eiko Lifesciences Ltd?
Before investing in Eiko Lifesciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.